[Selegiline in Parkinson's disease; symptomatic or causal effect?].
Wolters
E C
EC
Academisch Ziekenhuis Vrije Universiteit, afd. Neurologie, Amsterdam.
Kuiper
M A
MA
Horstink
M W
MW
D004734:Energy Metabolism; D005609:Free Radicals; D006801:Humans; D016660:NAD(P)H Dehydrogenase (Quinone) / Q000172:deficiency; D010084:Oxidation-Reduction; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism; D016032:Randomized Controlled Trials as Topic; D012642:Selegiline / Q000494:pharmacology / Q000627:therapeutic use*
D005609:Free Radicals; D012642:Selegiline; D016660:NAD(P)H Dehydrogenase (Quinone)
Selegiline bij de ziekte van Parkinson; symptomatisch of causaal effect?